Tumor Ablation Market Report 2026

Tumor Ablation Market Overview

• Tumor Ablation market size has reached to $1.62 billion in 2025 • Expected to grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.4% • Growth Driver: Rising Demand For Minimally Invasive Procedures Drives Growth In The Tumor Ablation Market • Market Trend: Innovative Developments In Bone Tumor Ablation Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tumor Ablation Market?

Tumor ablation is a minimally invasive medical procedure used to destroy cancerous tissues. It involves the application of extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This technique is often employed for small tumors or those in difficult-to-reach locations. The main type of tumor ablation are thermal ablation and chemical ablation. Thermal ablation refers to a medical procedure that uses extreme heat to destroy abnormal or diseased tissue. For various types of treatment such as percutaneous, laparoscopic, and surgical for applications in kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and others. The end users include hospitals, oncology centers, and others.

What Is The Tumor Ablation Market Growth Forecast?

The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for targeted cancer therapies, rising investments in precision oncology solutions, expansion of outpatient cancer treatment facilities, integration of ai-based treatment planning, growing focus on patient-centric cancer care. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of image-guided ablation technologies, growing preference for thermal ablation techniques, expansion of outpatient tumor treatment settings, enhanced focus on precision oncology.

Global Tumor Ablation Market Segmentation

1) By Type: Thermal Ablation, Chemical Ablation 2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical 3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer 4) By End Users: Hospitals, Oncology Centers, Other End Users Subsegments: 1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU) 2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Transarterial Chemoembolization

What Is The Driver Of The Tumor Ablation Market?

The rising adoption of minimally invasive procedures is expected to propel the growth of the tumor ablation market going forward. Minimally invasive interventions, including robot-assisted surgeries, are surgical techniques that use small or no incisions to reduce recovery time, minimize complications, and lower postoperative pain. This shift is driven by growing patient demand for faster recovery, advancements in surgical robotics, and improvements in imaging-guided treatment accuracy. Tumor ablation technologies such as radiofrequency, microwave, and cryoablation, align with this trend by enabling precise destruction of cancerous tissue while preserving surrounding healthy structures. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing use of minimally invasive procedures is driving the growth of the tumor ablation industry.

Key Players In The Global Tumor Ablation Market

Major companies operating in the tumor ablation market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Accuray Incorporated, AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd., Hologic Inc., Johnson & Johnson MedTech

Global Tumor Ablation Market Trends and Insights

Major companies operating in the tumor ablation market are developing innovative products, such as bone tumor ablation systems, to enhance treatment efficacy, improve patient outcomes, and expand the range of treatable tumors. A bone tumor ablation system is a specialized medical device used to treat bone tumors through minimally invasive procedures. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.bone tumor ablation system. The upgraded system is designed to treat painful bone metastases and benign bone tumors such as osteoi osteoma. The OsteoCool 2.0 allows for the simultaneous use of four internally cooled probes, enabling physicians to ablate two vertebral bodies at once or create larger ablation zones in extra-spinal applications. It delivers 20W per channel, more than twice the power of the Stryker OptaBlate bone tumor ablation system.

What Are Latest Mergers And Acquisitions In The Tumor Ablation Market?

In August 2025, K5 Global, a US-based investment and growth-oriented technology investment firm, acquired HistoSonics Inc., for $2.25 billion. With this acquisition, K5 Global aims to accelerate the commercialization and global rollout of HistoSonics’ non-invasive tumor-ablation platform and scale its clinical and regulatory footprint. HistoSonics is a US-based healthcare technology company that specializes in developing and providing the Edison histotripsy system, a focused-ultrasound solution for non-invasive soft-tissue tumor ablation.

Regional Outlook

North America was the largest region in the tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Tumor Ablation Market?

The tumor ablation market includes revenues earned by entities by providing services such as consultation, diagnosis, chemical ablation, and post-procedure care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.